1. Inicio
  2. Publicaciones
  3. De Novo Cancer in Liver Transplant Patients With HIV Infection: A Multicenter Nationwide Cohort Study.

De Novo Cancer in Liver Transplant Patients With HIV Infection: A Multicenter Nationwide Cohort Study.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Herrero JI
  • Agüero F
  • Manzardo C
  • Gastaca M
  • Salcedo M
  • Castells L
  • Lladó L
  • Calvo-Pulido J
  • Fortún J
  • Suarez F
  • Cordero E
  • Torre-Cisneros J
  • Subirana M
  • Montejo M
  • Bilbao I
  • Cachero A
  • Jimenez-Romero C
  • Del Campo S
  • Malano-Barletta D
  • Ruiz P
  • Moreno A
  • de la Rosa G
  • Rimola A
  • Miro JM
  • FIPSE LT-HIV investigators

Grupos

Abstract

BACKGROUND: Patients with human immunodeficiency virus (HIV) infection have been gradually accepted as solid organ transplant recipients, although there is still concern that the burden of immunosuppression and HIV infection could increase the risk of post-transplant cancer. METHODS: The risk of de novo cancer was evaluated in a prospective cohort of 272 HIV-positive and 816 matched HIV-negative liver transplant recipients in Spain (2002-2012). All tumors, except hepatocellular carcinoma recurrence and non-melanoma skin cancer, after liver transplant were considered as events and death as competing event in this study. RESULTS: Despite matching, patients with HIV were significantly younger (45.8 vs 49.3 years). Sixteen (5.9%) patients with HIV and 61 (7.5%) HIV-negative patients developed de novo cancers (P = .39) after a median follow-up of 59.8 and 72.3 months, respectively. The most frequently diagnosed types of tumors were non-Hodgkin lymphoma (n = 19), lung cancer (n = 14), and head and neck cancer (n = 14). Time of onset, distribution, and tumor stage at diagnosis were similar in both groups. The cumulative incidences of de novo cancer at 5 and 10 years were, respectively, 6% and 12% in patients with HIV and 6% and 13% in uninfected patients. Survival after cancer diagnosis did not differ between groups. The only factor related to the development of de novo cancers was a higher age at transplantation. CONCLUSIONS: Human immunodeficiency virus infection per se is not associated to a higher risk of de novo cancer after liver transplantation.

© The Author(s) 2026. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Datos de la publicación

ISSN/ISSNe:
1058-4838, 1537-6591

CLINICAL INFECTIOUS DISEASES  OXFORD UNIV PRESS INC

Tipo:
Article
Páginas:
160-169
PubMed:
41989878
Factor de Impacto:
4,394 SCImago ℠
Cuartil:
Q1 SCImago ℠

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • HCV infection; HIV infection; de novo cancer; liver transplantation; survival

Cita

Compartir